-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Century Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2022 to Q2 2024.
- Century Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $22K, a 97.7% decline year-over-year.
- Century Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$254K, a 111% decline year-over-year.
- Century Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $1.88M, a 1967% increase from 2022.
- Century Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $91K, a 112% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)